Stay updated on Medicenna Therapeutics Press Releases

Sign up to get notified when there's something new on the Medicenna Therapeutics Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Medicenna Therapeutics Press Releases page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now includes a report from Medicenna detailing the anti-cancer activity of MDNA11 and its association with the expansion of cancer-fighting immune cells, along with an update on the ABILITY-1 study presented at the AACR-Immuno-Oncology Conference.
    Difference
    43%
    Check dated 2025-03-03T22:15:34.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The web page now includes a report from Medicenna detailing their third quarter fiscal 2025 financial and operational results, along with anticipated milestones.
    Difference
    34%
    Check dated 2025-02-17T14:30:47.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The webpage has been updated to include a new event where Medicenna Therapeutics will participate in two healthcare investor conferences in February 2025, while significant past events and updates from 2024 have been removed.
    Difference
    91%
    Check dated 2025-02-10T09:32:52.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The website has added several new sections including a Management Team, Board of Directors, Clinical Advisory Board, and various resources related to news, events, financials, and investor relations.
    Difference
    29%
    Check dated 2025-02-03T06:00:10.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    The copyright year has been updated from 2024 to 2025 for Medicenna Therapeutics.
    Difference
    0.9%
    Check dated 2025-01-19T20:34:19.000Z thumbnail image
  9. Check
    103 days ago
    Change Detected
    Summary
    Medicenna has added a presentation of preclinical data on MDNA11 aimed at tumor shrinkage and metastasis prevention at the upcoming 2024 San Antonio Breast Cancer Symposium, while a previous announcement regarding positive activity and safety of MDNA11 in combination with KEYTRUDA has been removed.
    Difference
    29%
    Check dated 2024-12-14T22:31:27.000Z thumbnail image

Stay in the know with updates to Medicenna Therapeutics Press Releases

Enter your email address, and we'll notify you when there's something new on the Medicenna Therapeutics Press Releases page.